Haffkine Biopharma Enters Deal With Bharat Biotech to Produce 22.8 Cr Covaxin Doses Per Year

Under a technology transfer agreement with Bharat Biotech, Mumbai-based Haffkine will manufacture Covaxin.

Similar Articles

Most Popular